Buy or sell Emulate stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Emulate Stock

Organs-on-Chips Company

Founded

2013

Notable Investors

Glass Wall Syndicate

Headquarters

Boston MA, US

Total Funding

$95.0M

About Emulate Stock

Emulate, Inc. is a private company focused on commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for mimicking true human physiology so that responses to medicines, chemicals and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate is advancing product innovation, design and safety across a range of applications in drug development, personalized medicine, agriculture and chemical-based consumer products.

Investors

ALS Investment Fund

Emulate

ATEL Ventures

Emulate

Glass Wall Syndicate

Emulate

National Institutes of Health

Emulate, Owlet Baby Care

SciFi VC

Synthego, Emulate

Techammer

Emulate

Funding History

July 2014$12.0M
March 2016$28.0M
October 2016$17.0M
June 2017$2.0M
June 2018$36.0M

Management

Co-Founder & Chief Science Officer

Geraldine A. Hamilton

Chief Executive Officer

Martin Madaus

Chief Technology Officer

Daniel Levner

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Emulate or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo